Cargando…
Proteome and phosphoproteome signatures of recurrence for HPV(+) head and neck squamous cell carcinoma
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and the human papillomavirus (HPV(+))-driven subtype is the fastest rising cancer in North America. Although most cases of HPV(+) HNSCC respond favorably to the treatment via surgery followed by radio...
Autores principales: | Kaneko, Tomonori, Zeng, Peter Y. F., Liu, Xuguang, Abdo, Rober, Barrett, John W., Zhang, Qi, Nichols, Anthony C., Li, Shawn Shun-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338924/ https://www.ncbi.nlm.nih.gov/pubmed/35919862 http://dx.doi.org/10.1038/s43856-022-00159-8 |
Ejemplares similares
-
Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas
por: Degli Esposti, Davide, et al.
Publicado: (2017) -
HPV-Related Prognostic Signature Predicts Survival in Head and Neck Squamous Cell Carcinoma
por: Zhao, Hongyu, et al.
Publicado: (2022) -
Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019) -
The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020) -
Distinguishable Prognostic miRNA Signatures of Head and Neck Squamous Cell Cancer With or Without HPV Infection
por: Luo, Xiao-jie, et al.
Publicado: (2021)